Subscribe To
Natera announces completion of the largest prospective validation study of a commercial cell-free dna test in lung transplantation
AUSTIN, Texas, Oct. 6, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in improving patient outcomes through genetic and cell-free DNA (cf...
October 6, 2021, 8:33 am
Natera announces completion of the largest prospective validation study of a commercial cell-free dna test in lung transplantation
AUSTIN, Texas, Oct. 6, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in improving patient outcomes through genetic and cell-free DNA (cf...
October 6, 2021, 8:33 am
Natera announces completion of the largest prospective validation study of a commercial cell-free dna test in lung transplantation
AUSTIN, Texas, Oct. 6, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in improving patient outcomes through genetic and cell-free DNA (cf...
October 6, 2021, 8:33 am